Los Angeles Capital Management
ETON icon

Los Angeles Capital Management’s Eton Pharmaceutcials ETON Stock Holding History

Los Angeles Capital Management’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$253K Sell
10,269
-4,362
-30% -$76.3K ﹤0.01% 1078
2025
Q4 		$267K Buy
+14,631
New +$257K ﹤0.01% 1134

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Los Angeles Capital Management's ETON Position: Q1 2026 in Review

Los Angeles Capital Management reduced its Eton Pharmaceutcials (ETON) stake by 30% in Q1 2026, selling an estimated $76.3K and leaving 10,269 shares worth $253K. The position accounts for ﹤0.01% of the portfolio, ranked #1078.

Los Angeles Capital Management first reported a position in ETON in Q4 2025 and has held it in 2 quarters since. The position peaked at $267K in Q4 2025. 116 funds tracked by Wall St. Rank hold ETON as of Q1 2026.

  • Los Angeles Capital Management held 10,269 shares of Eton Pharmaceutcials worth $253K as of Q1 2026.
  • Los Angeles Capital Management sold 4,362 Eton Pharmaceutcials shares in Q1 2026, an estimated $76.3K.
  • Eton Pharmaceutcials made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q1 2026, its #1078 holding.
  • Los Angeles Capital Management first reported a position in Eton Pharmaceutcials in Q4 2025 and has held it in 2 quarters since.
  • Los Angeles Capital Management's Eton Pharmaceutcials position peaked at $267K in Q4 2025.
  • 116 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2026.

Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.